Editorial · 2022 · Open access
What's in a name? Nomenclature in immunology
Immunology, 167(2), 123 · Published 27 September 2022 · DOI 10.1111/imm.13576
In brief
“What's in a name? Nomenclature in immunology” is an 2022 editorial by Greg M. Delgoffe, published in Immunology. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at Immunology.
- Citations
- 0
- References
- 1
- Authors
- 1
Abstract
Immunology is famous (or perhaps, infamous) for having extremely complex nomenclature. While this is critically important for making sure we are all on the same page when interpreting data and evaluating findings and conclusions, the fact is, outside of immunology, our alphabet soup of cell types has been derisively termed ‘immuno-speak’. However, as famously posited by Orwell, language can shape our thinking, our interpretation of reality. So it is critically important for our field that we are clear. While I think it would be a major leap to suggest we standardize nomenclature so that non-immunologists can easily understand our findings on first read, I think a more pressing concern is confusions about terminology and nomenclature within the field. While certain features like cluster of differentiation molecules and interleukins have rather rigorous nomenclature, this is mostly borne out in cell subsets. Indeed, it is not uncommon to be at an immunology-centred conference and hear a lively discussion at the podium about certain cell types and their markers, only for ultimately the two parties to ultimately realize they were talking about the same cell! To me, the problem is that apart from a few key publications (which, admittedly, are now quite dated), the fact is there is no ‘home’ for issues of nomenclature. In fact, discussions of new subsets are often simply relegated to the discussion of primary research. Whether the field agrees is left to chance, and then corrected/normalized later on. More often, these ‘standardization’ type papers arise quite organically: usually at a meeting, a critical mass of researchers in a certain cell type decide ‘enough is enough’ and discuss a perspective on naming that subset, with the hope that it sticks long term. A rather notable example was in the regulatory T (Treg) cell field, in which ‘natural’ Treg cells and ‘induced’ Treg cells evolved into several new subsets, including those that arose in the thymus (tTreg), the periphery (pTreg), or from in vitro culture (iTreg) [1]. However, since that time, we now have new Treg cell subsets, like ‘central’ or ‘effector’ Treg cells. This transcends the field, especially in how we subset cells, but also more broader topics. Disease models, systems, mice, and even reagents or techniques can succumb to issues of nomenclature. It can be dizzying and confusing for newcomers, but also create schisms in the field (I will not even get into the field of T cell exhaustion). So, perhaps we can work to create some clarity here at the Journal. In the coming weeks, I will…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Delgoffe, G. M. (2022). What's in a name? Nomenclature in immunology. Immunology, 167(2), 123. https://doi.org/10.1111/imm.13576
MLA 9
Delgoffe, Greg M. “What's in a name? Nomenclature in immunology.” Immunology, vol. 167, no. 2, 2022, p. 123. https://doi.org/10.1111/imm.13576.
Chicago
Delgoffe, Greg M. 2022. “What's in a name? Nomenclature in immunology.” Immunology 167 (2): 123. https://doi.org/10.1111/imm.13576.
Harvard
Delgoffe, G. M. (2022) ‘What's in a name? Nomenclature in immunology’, Immunology, 167(2), p. 123. doi:10.1111/imm.13576.
IEEE
G. M. Delgoffe, “What's in a name? Nomenclature in immunology,” Immunology, vol. 167, no. 2, p. 123, 2022, doi: 10.1111/imm.13576.
BibTeX
@article{delgoffe2022what,
title = {{What's in a name? Nomenclature in immunology}},
author = {Delgoffe, Greg M.},
journal = {Immunology},
year = {2022},
volume = {167},
number = {2},
pages = {123},
doi = {10.1111/imm.13576},
url = {https://doi.org/10.1111/imm.13576}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- terminology standardization
- regulatory T cells
- interleukins
- nomenclature committee
- science communication
- T cell exhaustion
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Delgoffe, G. M. (2022). What's in a name? Nomenclature in immunology. Immunology, 167(2), 123. https://doi.org/10.1111/imm.13576
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Immunology: sign in and open the PDF from this page.
Who wrote this paper?
Greg M. Delgoffe.
What is the DOI of this paper?
10.1111/imm.13576, permanently at https://doi.org/10.1111/imm.13576. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.